From the Department of Imaging (F.G.M.), Cedars-Sinai Medical Center, Los Angeles, California
Divisions of Cardiology and Vascular Surgery, Medical University of South Carolina (T.M.T.), Charleston, South Carolina.
AJNR Am J Neuroradiol. 2022 Mar;43(3):381-387. doi: 10.3174/ajnr.A7412. Epub 2022 Feb 10.
Hemorrhagic transformation is a critical complication associated with ischemic stroke and has been associated with contrast media administration. The objective of our study was to use real-world in-hospital data to evaluate the correlation between contrast media type and transformation from ischemic to hemorrhagic stroke.
We obtained data on inpatient admissions with a diagnosis of ischemic stroke and a record of either iso-osmolar or low-osmolar iodinated contrast media for a stroke-related diagnostic test and a treatment procedure (thrombectomy, thrombolysis, or angioplasty). We performed multivariable regression analysis to assess the relationship between contrast media type and the development of hemorrhagic transformation during hospitalization, adjusting for patient characteristics, comorbid conditions, procedure type, a threshold for contrast media volume, and differences across hospitals.
Inpatient visits with exclusive use of either low-osmolar ( = 38,130) or iso-osmolar contrast media ( = 4042) were included. We observed an overall risk reduction in hemorrhagic transformation among patients who received iso-osmolar compared with low-osmolar contrast media, with an absolute risk reduction of 1.4% (= .032), relative risk reduction of 12.5%, and number needed to prevent harm of 70. This outcome was driven primarily by patients undergoing endovascular thrombectomy ( = 9211), in which iso-osmolar contrast media was associated with an absolute risk reduction of 4.6% (= .028), a relative risk reduction of 20.8%, and number needed to prevent harm of 22, compared with low-osmolar contrast media.
Iso-osmolar contrast media was associated with a lower rate of hemorrhagic transformation compared with low-osmolar contrast media in patients with ischemic stroke.
出血转化是缺血性卒中的一种严重并发症,与对比剂的使用有关。本研究旨在利用真实世界的住院数据,评估对比剂类型与缺血性卒中向出血性卒中转化之间的相关性。
我们获取了因缺血性卒中住院且有卒中相关诊断性检查和治疗性操作(取栓术、溶栓或血管成形术)记录的等渗或低渗碘对比剂的住院患者数据。我们采用多变量回归分析,在校正患者特征、合并症、操作类型、对比剂用量阈值和医院间差异后,评估对比剂类型与住院期间出血转化的关系。
共纳入仅使用低渗( = 38130)或等渗( = 4042)对比剂的住院患者。与低渗对比剂相比,使用等渗对比剂的患者出血转化风险总体降低,绝对风险降低 1.4%( = .032),相对风险降低 12.5%,危害预防数为 70。该结果主要由接受血管内取栓术的患者( = 9211)驱动,与低渗对比剂相比,等渗对比剂的绝对风险降低 4.6%( = .028),相对风险降低 20.8%,危害预防数为 22。
与低渗对比剂相比,等渗对比剂与缺血性卒中患者出血转化发生率降低相关。